EKF Diagnostics Investor Announcements


EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.

EKF Diagnostics Holdings plc announces that it has signed an agreement with Source BioScience UK Ltd

EKF Diagnostics Holdings plc announces that further to yesterday’s announcement regarding the significant increase in manufacturing demand for the PrimeStore MTM sample collection device

EKF Diagnostics Holdings plc provides an update on the significant increase in manufacturing demand from Longhorn Vaccines and Diagnostics LLC  in the US.

7th Apr 2020

EKF Diagnostics Holdings plc announces its final results for the year ended 31 December 2019.

EKF Diagnostics Holdings plc provides shareholders with an update on current trading in light of the COVID-19 pandemic

EKF Diagnostics will announce its preliminary results for the year ended 31 December 2019 on Tuesday 24 March 2020.

EKF Diagnostics announces that it will release its preliminary results for the year ended 31 December 2019 on Tuesday 24 March 2020.

Standard form for notification of major holdings. 

29th Jan 2020

EKF Diagnostics provides the following the trading update for the year ended 31 December 2019.

EKF Diagnostics provides shareholders with the following update on current trading and performance bonuses.